REGAIN STUDY: Retrospective Study to Assess the Effectiveness, Tolerability, and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnant Women

Table 1

Body weight and vital signs (pre- and postinfusion timepoint).

		Weight (kg)	Systolic blood pressure (mmHg)	Diastolic blood pressure (mmHg)	Heart rate (beats/min)
Preinfusion timepoint
N	Valid	995	996	996	991
	Missing	6	5	5	10
Mean		75.95	109.71	66.85	90.49
Std. deviation		15.49	10.77	8.23	11.23
Range (min–max)		115 (38–153)	114 (81–195)	61 (37–98)	77 (56–133)
Postinfusion timepoint
N	Valid	250	904	903	900
	Missing	751	97	98	101
Mean		73.32	105.69	64.58	88.01
Std. deviation		15.46	10.63	8.37	10.44
Range (min–max)		81 (44–126)	90 (84–174)	54 (44–98)	58 (60–118)